Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 CAD | -1.52% | -2.99% | -16.67% |
Jun. 04 | Microbix Advancing Test-Ingredient Manufacturing Capabilities | MT |
Jun. 04 | Microbix Brief: Advancing Test-Ingredient Manufacturing Capabilities | MT |
Sales 2024 * | 18.52M 25.44M | Sales 2025 * | 21.39M 29.38M | Capitalization | 32.34M 44.42M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.75 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.51 x |
P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
16.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.86% |
Latest transcript on Microbix Biosystems Inc.
1 day | -1.52% | ||
1 week | -2.99% | ||
Current month | +1.56% | ||
1 month | +1.56% | ||
3 months | -13.33% | ||
6 months | -12.16% | ||
Current year | -16.67% |
Managers | Title | Age | Since |
---|---|---|---|
Cameron Groome
CEO | Chief Executive Officer | - | 12-03-07 |
James Currie
DFI | Director of Finance/CFO | - | 16-10-31 |
Mark Luscher
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Cochran
BRD | Director/Board Member | - | 90-09-30 |
Peter Blecher
BRD | Director/Board Member | - | 05-12-05 |
Cameron Groome
CEO | Chief Executive Officer | - | 12-03-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 0.325 | -1.52% | 52,500 |
24-06-13 | 0.33 | -5.71% | 60,000 |
24-06-12 | 0.35 | +2.94% | 22,500 |
24-06-11 | 0.34 | 0.00% | 62,000 |
24-06-10 | 0.34 | +1.49% | 13,075 |
Delayed Quote Toronto S.E., June 14, 2024 at 03:31 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.67% | 32.34M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- MBX Stock